RPFNA Assessment of Exercise Effect in Breast Cancer



Status:Recruiting
Conditions:Breast Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - 50
Updated:5/3/2014
Start Date:October 2011
Contact:Jennifer Ligibel, MD
Email:jligibel@partners.org
Phone:617-632-3800

Use our guide to learn which trials are right for you!

Pilot Feasibility Study of the Use of Random Periareolar Fine Needle Aspiration Exercise Induced Changes in Breast Tissue

This study is being done to see if the investigators can measure changes that occur in
breast tissue when women at risk of developing breast cancer start an exercise program. The
investigators are interested in studying this because research shows that women who exercise
regularly are less likely to develop breast cancer, but there is not very much information
explaining how exercise could affect breast cells in a way to prevent cancer from occurring.
In this research study the investigators will use a research technique called breast random
fine needle aspiration (RPFNA) to test breast cells for their shape and how they look. The
investigators will look at breast cells before and after a participant takes part in an
exercise program to see if the investigators are able to see any changes in breast cells
that could have happened due to the exercise program. This research will help us to develop
larger projects to see if exercise programs could be helpful in preventing breast cancer.


Inclusion Criteria:

- History of lobular carcinoma in situ, atypical ductal/lobular hyperplasia on prior
breast biopsy or lifetime risk of breast cancer of at least 20% based on any risk
model, or personal history of BRCA1 or 2 mutation

- Physically able to exercise and physician consent to start an exercise program

- Sedentary activity pattern

- Premenopausal

- English speaking and able to read English

Exclusion Criteria:

- History of invasive breast cancer or ductal carcinoma in situ

- Absolute contraindications to maximal exercise testing as recommended by the American
Thoracic Society

- Any condition which in the investigator's opinion makes the subject unsuitable for
study participation

- Participating in another clinical study with competing study outcomes

- Pregnant or breastfeeding

- Unable to comply with protocol and/or not available for follow-ups

- Type II Diabetes

- Allergic to local anesthetics

- History of bilateral or unilateral mastectomy
We found this trial at
1
site
450 Brookline Ave
Boston, Massachusetts 2215
617-632-3000
Dana-Farber Cancer Institute Since it’s founding in 1947, Dana-Farber has been committed to providing adults...
?
mi
from
Boston, MA
Click here to add this to my saved trials